1.
Chollat C, Tourrel F, Marret S: Does remifentanil have a place for sedation in the case of endotracheal intubation or minimally invasive surfactant therapy in neonates? Neonatology 2017;112:372-373.
2.
de Kort EHM, Hanff LM, Roofthooft D, Reiss IKM, Simons SHP: Insufficient sedation and severe side effects after fast administration of remifentanil during INSURE in preterm newborns. Neonatology 2017;111:172-176.
3.
Choong K, Alfaleh K, Doucette J, Gray S, Rich B, Verhey L, Paes B: Remifentanil for endotracheal intubation in neonates: a randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 2010;95:F80-F84.
4.
Avino D, Zhang WH, De Ville A, Johansson AB: Remifentanil versus morphine-midazolam premedication on the quality of endotracheal intubation in neonates: a non-inferiority randomized trial. J Pediatr 2014;164:1032-1037.
5.
Badiee Z, Vakiliamini M, Mohammedizadeh M: Remifentanil for endotracheal intubation in premature infants: a randomized controlled trial. J Res Pharm Pract 2013;2:75-82.
6.
Pereira e Silva Y, Gomez RG, Marcatto J, Maximo TA, Barbosa RF, Simões e Silva AC: Morphine versus remifentanil for intubating preterm neonates. Arch Dis Child Fetal Neonatal Ed 2007;92:F293-F294.
7.
Welzing L, Kribs A, Huenseler C, Eifinger F, Mehler K, Roth B: Remifentanil for INSURE in preterm infants: a pilot study for evaluation of efficacy and safety aspects. Acta Paediatr 2009;98:1416-1420.
8.
Buthada A, Sahni R, Rastogi S, Wung JT: Randomised controlled trial of thiopental for intubation in neonates. Arch Dis Child Fetal Neonatal Ed 2000;82:F34-F37.
9.
Oei J, Hari R, Butha T, Lui K: Facilitation of neonatal nasotracheal intubation with premedication: a randomized controlled trial. J Paediatr Child Health 2002;38:146-150.
10.
Barrington KJ, Finer NN, Etches PC: Succinylcholine and atropine for premedication of the newborn infant before nasotracheal intubation: a randomized, controlled trial. Crit Care Med 1989;17:1293-1296.
11.
Carbajal R, Eble B, Anand KJS: Premedication for tracheal intubation in neonates: confusion or controversy? Semin Perinatol 2007;31:309-317.
12.
Kumar P, Denson SE, Mancuso TJ, et.al: Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics 2010;125:608-615.
13.
Byrne E, MacKinnon R: Should premedication be used for semi-urgent or elective intubation in neonates? Arch Dis Child 2006;91:79-83.
14.
Penido MG, Garaa R, Sammartino M, Pereira e Silva Y: Remifentanil in neonatal intensive care and anaesthesia practice. Acta Paediatr 2010;99:1454-1463.
© 2016 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2016 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.